Erratum

Erratum for the Research Article: “The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study” by P. Kiessling, R. Lledo-Garcia, S. Watanabe, G. Langdon, D. Tran, M. Bari, L. Christodoulou, E. Jones, G. Price, B. Smith, F. Brennan, I. White, S. Jolles

See allHide authors and affiliations

Science Translational Medicine  06 Dec 2017:
Vol. 9, Issue 419, eaar6448
DOI: 10.1126/scitranslmed.aar6448

Article Information

vol. 9 no. 419

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • .
Other Contributors: 
  • American Association for the Advancement of Science

Author Information

Altmetric

Article usage

Article usage: December 2017 to February 2021

AbstractFullPdf
Dec 2017029000
Jan 201801240
Feb 20180770
Mar 20180620
Apr 20180670
May 201801010
Jun 20180600
Jul 20180500
Aug 201801040
Sep 20180640
Oct 20180790
Nov 20180460
Dec 20180480
Jan 20190580
Feb 20190710
Mar 20190840
Apr 20190612
May 20190400
Jun 20190381
Jul 20190601
Aug 20190281
Sep 20190470
Oct 20190402
Nov 20190570
Dec 20190280
Jan 20200581
Feb 20200480
Mar 20200371
Apr 20200342
May 20200201
Jun 20200241
Jul 20200251
Aug 20200263
Sep 20200391
Oct 20200343
Nov 20200371
Dec 20200300
Jan 20210180
Feb 20210410

Stay Connected to Science Translational Medicine

Navigate This Article